Home » RECKITT BENCKISER TO BUY OTC UNIT
RECKITT BENCKISER TO BUY OTC UNIT
Household products group Reckitt Benckiser on Friday won an auction to buy Boots Group's over-the-counter drugs unit, Boots Healthcare International, for 1.93 billion pounds ($3.42 billion) in cash. Reckitt Benckiser (UK:RB: news, chart, profile) won an auction that included GlaxoSmithKline (GSK: news, chart, profile) and Bayer (BAY: news, chart, profile) for the unit that makes Nurofen, the world's second-most popular Ibuprofen brand; Strepsils, the world's top sore throat medication; and the Clearasil anti-acne drug.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May